Kim Major‐Walker

1.4k total citations · 1 hit paper
10 papers, 919 citations indexed

About

Kim Major‐Walker is a scholar working on Urology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kim Major‐Walker has authored 10 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Urology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kim Major‐Walker's work include Urinary Bladder and Prostate Research (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Hormonal and reproductive studies (5 papers). Kim Major‐Walker is often cited by papers focused on Urinary Bladder and Prostate Research (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Hormonal and reproductive studies (5 papers). Kim Major‐Walker collaborates with scholars based in United States, Italy and Canada. Kim Major‐Walker's co-authors include Claus G. Roehrborn, Betsy Morrill, Paul Siami, Jack Barkin, Ronaldo Damião, Francesco Montorsi, Indrani Nandy, R. Paul Gagnier, Jennifer B. Shannon and Roger S. Rittmaster and has published in prestigious journals such as The Journal of Urology, European Urology and Prostate Cancer and Prostatic Diseases.

In The Last Decade

Kim Major‐Walker

9 papers receiving 886 citations

Hit Papers

The Effects of Combination Therapy with Dutasteride and T... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Major‐Walker United States 7 819 552 354 308 92 10 919
K J Hoefner United States 3 624 0.8× 461 0.8× 275 0.8× 265 0.9× 46 0.5× 4 737
Johnny Roy United States 7 464 0.6× 310 0.6× 190 0.5× 220 0.7× 41 0.4× 8 571
Weining Volinn United States 9 359 0.4× 142 0.3× 163 0.5× 163 0.5× 47 0.5× 15 423
Claus Roehrborn United States 13 425 0.5× 309 0.6× 187 0.5× 110 0.4× 33 0.4× 43 488
R. Vela‐Navarrete Spain 13 399 0.5× 201 0.4× 119 0.3× 201 0.7× 30 0.3× 35 579
Tania Hossack Australia 11 282 0.3× 320 0.6× 177 0.5× 98 0.3× 40 0.4× 21 530
Ahmed Fawzy Egypt 8 274 0.3× 91 0.2× 86 0.2× 177 0.6× 44 0.5× 27 392
M. Cemil Uygur Türkiye 13 267 0.3× 133 0.2× 114 0.3× 98 0.3× 16 0.2× 35 454
A. Thorpe United Kingdom 5 210 0.3× 120 0.2× 84 0.2× 73 0.2× 16 0.2× 12 311
Emily E. Cole United States 13 245 0.3× 92 0.2× 159 0.4× 60 0.2× 50 0.5× 18 545

Countries citing papers authored by Kim Major‐Walker

Since Specialization
Citations

This map shows the geographic impact of Kim Major‐Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Major‐Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Major‐Walker more than expected).

Fields of papers citing papers by Kim Major‐Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Major‐Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Major‐Walker. The network helps show where Kim Major‐Walker may publish in the future.

Co-authorship network of co-authors of Kim Major‐Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Major‐Walker. A scholar is included among the top collaborators of Kim Major‐Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Major‐Walker. Kim Major‐Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chung, Byung Ha, Seung Hwan Lee, Claus G. Roehrborn, et al.. (2012). Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: Long‐term results from the combination of dutasteride and tamsulosin study. International Journal of Urology. 19(11). 1031–1035. 10 indexed citations
2.
Roehrborn, Claus G., Paul Siami, Jack Barkin, et al.. (2009). The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study. European Urology. 57(1). 123–131. 528 indexed citations breakdown →
3.
Chung, Byung Ha, Claus G. Roehrborn, Paul Siami, et al.. (2008). Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH. Prostate Cancer and Prostatic Diseases. 12(2). 152–159. 17 indexed citations
4.
Becher, Edgardo, Claus G. Roehrborn, Paul Siami, et al.. (2008). IMPROVEMENTS IN STORAGE AND VOIDING SYMPTOMS WITH DUTASTERIDE, TAMSULOSIN AND THE COMBINATION: POST- HOC ANALYSIS OF THE 2-YEAR DATA FROM THE CombAT TRIAL. The Journal of Urology. 179(4S). 698–699.
7.
Ray, Paul S., et al.. (2006). The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia. Prostate Cancer and Prostatic Diseases. 10(2). 149–154. 55 indexed citations
8.
Roehrborn, Claus, et al.. (2006). BASELINE DATA FROM THE COMBINATION OF AVODART™ AND TAMSULOSIN (COMBAT) TRIAL: RELATIONSHIPS BETWEEN BODY MASS INDEX (BMI) AND LUTS/BPH MEASURES. European Urology Supplements. 5(2). 195–195. 7 indexed citations
9.
Montorsi, Francesco, et al.. (2006). RACIAL DIFFERENCES IN BASELINE CHARACTERISTICS IN THE COMBINATION OF AVODART™ AND TAMSULOSIN (COMBAT) TRIAL. European Urology Supplements. 5(2). 196–196. 1 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026